{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:38:44Z","timestamp":1792114724364,"version":"4.4.0"},"reference-count":34,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T00:00:00Z","timestamp":1442534400000},"content-version":"unspecified","delay-in-days":13378,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can. j. neurol. sci."],"published-print":{"date-parts":[[1979,2]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Sixteen patients with narcolepsy and cataplexy were treated with gamma-hydroxybutyrate (GHB) given at night and tailored to achieve as continuous a night's sleep as possible. The dosage usually consisted of 1.5-2.25 gm orally at bedtime and then one or two further 1.0-1.5 gm doses with awakenings during the night, and totaled about 50 mg \/kg. Apart from one patient who took only the bedtime dose, the subjective quality of night sleep improved in all patients and the number of irresistable daytime attacks of sleep and cataplexy substantially diminished. Some residual daytime drowsiness remained and this usually responded well to low doses of methylphenidate. Improvement has been maintained for up to 20 months without the development of tolerance. Two patients experienced adverse side effects necessitating withdrawal of GHB treatment, but no serious toxic effects have occurred.<\/jats:p>","DOI":"10.1017\/s0317167100119304","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T11:33:01Z","timestamp":1469705581000},"page":"1-6","source":"Crossref","is-referenced-by-count":135,"title":["The Treatment of Narcolepsy-Cataplexy with Nocturnal Gamma-Hydroxybutyrate"],"prefix":"10.1017","volume":"6","author":[{"given":"Roger","family":"Broughton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mortimer","family":"Mamelak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2015,9,18]]},"reference":[{"key":"S0317167100119304_ref027","first-page":"3012","article-title":"Mechanism of the gamma-hydroxybutyrate induced increase in brain dopamine and its relationships to \u201csleep","volume":"3001","author":"Roth","year":"1970","journal-title":"Biochem. Pharmacol."},{"key":"S0317167100119304_ref033","first-page":"558","article-title":"Effect of butyrolactone and gammahydroxybutyrate in the EEG and sleep cycle in man. Electroencephalogr.","volume":"22","author":"Yamada","year":"1967","journal-title":"Clin. Neuro-physio."},{"key":"S0317167100119304_ref023","volume-title":"Psychothera-peutic Drugs","author":"Muzard","year":"1977"},{"key":"S0317167100119304_ref016","first-page":"1313","article-title":"Effets du 4-butyrolactone et du 4-hydroxybutyrate de sodium sur l'EEG et le comportement du chat.","volume":"155","author":"Jouvet","year":"1961","journal-title":"C. R. Soc. Biol. (Paris)"},{"key":"S0317167100119304_ref021","first-page":"43","volume-title":"Narcolepsy","author":"Montplaisir","year":"1976"},{"key":"S0317167100119304_ref005","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0025-7125(16)33982-7","article-title":"Narcolepsy.","volume":"44","author":"Daly","year":"1960","journal-title":"Med. Clin. North Am."},{"key":"S0317167100119304_ref017","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(64)90074-7"},{"key":"S0317167100119304_ref025","first-page":"428","author":"Roth","year":"1962"},{"key":"S0317167100119304_ref013","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8986.1973.tb00801.x"},{"key":"S0317167100119304_ref020","first-page":"398","article-title":"Narcolepsy syndromes: antecedent, contiguous and concomitant nocturnal sleep disordering and deprivation.","volume":"4","author":"Mitchell","year":"1968","journal-title":"Psychophysiology"},{"key":"S0317167100119304_ref010","first-page":"270","article-title":"Identification of gamma-hydroxybutyric acid as an endogenous metabolite present in monkey and human brain.","volume":"35","author":"Doherty","year":"1976","journal-title":"Fed. Proc"},{"key":"S0317167100119304_ref007","first-page":"41","article-title":"Neurochemical and physiological aspects of gamma-hydroxy-butyric acid as a natural soporific.","volume":"1","author":"De La Mora","year":"1970","journal-title":"Ann. Instit. Boil. Auton. Mex."},{"key":"S0317167100119304_ref031","first-page":"673","article-title":"Effect of sodiumsalt of gamma-hydroxybutyric acid on synaptic transmission in the spinal cord.","volume":"24","author":"Uspenskii","year":"1965","journal-title":"Fed. Proc."},{"key":"S0317167100119304_ref004","first-page":"369","volume-title":"In L-Dopa and Parkinsonism","author":"Cordeau","year":"1970"},{"key":"S0317167100119304_ref003","first-page":"659","volume-title":"In Narcolepsy","author":"Broughton","year":"1976"},{"key":"S0317167100119304_ref011","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-196411000-00007"},{"key":"S0317167100119304_ref006","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-193413010-00001"},{"key":"S0317167100119304_ref032","doi-asserted-by":"publisher","DOI":"10.1097\/00004311-196900710-00007"},{"key":"S0317167100119304_ref015","doi-asserted-by":"publisher","DOI":"10.1126\/science.163.3862.32"},{"key":"S0317167100119304_ref024","doi-asserted-by":"publisher","DOI":"10.1016\/0013-4694(63)90032-4"},{"key":"S0317167100119304_ref014","doi-asserted-by":"publisher","DOI":"10.1139\/y69-146"},{"key":"S0317167100119304_ref018","first-page":"273","article-title":"The effects of gamma-hydroxybutyrate on sleep.","volume":"12","author":"Mamblak","year":"1977","journal-title":"Biol. Psychiatry"},{"key":"S0317167100119304_ref030","first-page":"69","article-title":"Effect of gammahydroxybutyrate on the synthesis rate of brain amines.","volume":"1","author":"Spano","year":"1970","journal-title":"Trans. Am. Soc. Neurochem."},{"key":"S0317167100119304_ref019","doi-asserted-by":"publisher","DOI":"10.1126\/science.146.3649.1328"},{"key":"S0317167100119304_ref034","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197305312882205"},{"key":"S0317167100119304_ref002","first-page":"201","volume-title":"impact of compound narcolepsy on the life of the patient. In Narcolepsy","author":"Broughton","year":"1976"},{"key":"S0317167100119304_ref028","first-page":"483","article-title":"Gammahydroxybutyrate: Effects on Nonstriated Dopaminergic Neurons.","volume":"16","author":"Roth","year":"1977","journal-title":"Adv. Biochem. Psychopharmacol."},{"key":"S0317167100119304_ref029","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(77)90171-0"},{"key":"S0317167100119304_ref026","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(69)90032-X"},{"key":"S0317167100119304_ref008","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0095-4543(21)00568-6","article-title":"Narcolepsy: diagnosis and treatment.","volume":"3","author":"Dement","year":"1976","journal-title":"Primary Care"},{"key":"S0317167100119304_ref012","doi-asserted-by":"publisher","DOI":"10.1016\/0013-4694(76)90210-8"},{"key":"S0317167100119304_ref022","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1972.tb27827.x"},{"key":"S0317167100119304_ref001","doi-asserted-by":"publisher","DOI":"10.1177\/070674377101600402"},{"key":"S0317167100119304_ref009","first-page":"147","article-title":"The prevalence of narcolepsy, II.","volume":"2","author":"Dement","year":"1973","journal-title":"Sleep Research"}],"container-title":["Canadian Journal of Neurological Sciences \/ Journal Canadien des Sciences Neurologiques"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0317167100119304","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T01:27:27Z","timestamp":1656898047000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0317167100119304\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1979,2]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1979,2]]}},"alternative-id":["S0317167100119304"],"URL":"https:\/\/doi.org\/10.1017\/s0317167100119304","relation":{},"ISSN":["0317-1671","2057-0155"],"issn-type":[{"value":"0317-1671","type":"print"},{"value":"2057-0155","type":"electronic"}],"subject":[],"published":{"date-parts":[[1979,2]]}}}